Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

অনুরূপ উপাদানগুলি

• Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
  অনুযায়ী: Munzone, E., অন্যান্য
  প্রকাশিত: (2015)
• Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer
  অনুযায়ী: Viale, G., অন্যান্য
  প্রকাশিত: (2010)
• Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
  অনুযায়ী: Regan, Meredith M, অন্যান্য
  প্রকাশিত: (2011)
• Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial
  অনুযায়ী: Metzger Filho, Otto, অন্যান্য
  প্রকাশিত: (2015)
• Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy
  অনুযায়ী: Maiorano, Eugenio, অন্যান্য
  প্রকাশিত: (2009)